The implementation of prolonged exposure: Design of a multisite study evaluating the usefulness of workshop with and without consultation

Foa, Edna B.; McLean, Carmen P.; Zandberg, Laurie J.; Zang, Yong; Asnaani, Anu; Benhamou, Kathy; Rosenfield, David; Campbell, H. Sharon; Francis, Jeremy; Hanson, Brenda S.; Lillard, Ivett J.; Patterson, Thomas J.; Scott, Valerie; Weber, Charles E.; Wise, Joseph E.; Zamora, Charles; Mintz, Jim; Young‐McCaughan, Stacey; Peterson, Alan L.

doi:10.1016/j.cct.2017.07.018

Cited by 2 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Immunodeficiency is a well-described association with 22q11.2 deletion syndrome, the severity of which can cover a range of phenotypic possibilities from a normal life to severe combined immunodeficiency (SCID) syndrome. The immunodeficiency associated with 22q11.2 deletion syndrome is primarily due to varying degrees of hypoplasia or aplasia of the thymus which leads to deficiency of number and/or function of T cells 7 8. Severe T-cell deficiency or absent T cells in early life leads to SCID with multiple early opportunistic infections and high mortality.…”

Section: Discussionmentioning

confidence: 99%

Bartonella henselaemasquerading as possible gamma–delta T-cell lymphoma in a paediatric patient with 22q11.2 deletion syndrome

et al. 2021

View full text Add to dashboard Cite

A 14-year-old boy with 22q11.2 deletion syndrome and a right ventricular to pulmonary artery xenograft conduit presented to an Australian tertiary children’s hospital with prolonged fevers, weight loss, splenomegaly and a high proportion of gamma–delta T cells in peripheral blood and bone marrow, concerning for possible gamma–delta T-cell lymphoma. However, investigations did not reveal evidence of lymphoma or autoimmune disease. After 5 months of intermittent fever episodes and ongoing symptoms, he was found to have an extremely high Bartonella henselae titre (8192) on serological testing, with the organism also detected on blood PCR. After 6 months of oral azithromycin and rifampicin, with complete resolution of his symptoms 3 months into treatment, his blood PCR was negative and gamma–delta T cells in peripheral blood were decreasing. The B. henselae titre remained unchanged for some time, but decreased to 2048 around 1 year after treatment was started.

show abstract

Section: Discussionmentioning

confidence: 99%

Bartonella henselaemasquerading as possible gamma–delta T-cell lymphoma in a paediatric patient with 22q11.2 deletion syndrome

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In a similar vein, the Center for Research on Eating Disorders at Oxford (CREDO) is taking a large-scale approach in the United Kingdom and across the United States to examine whether practitioners are more likely to use ESTs for eating disorders as part of their practice when given this training via an independent versus guided web training (Fairburn & Cooper, 2011; Fairburn & Patel, 2014). Several other studies funded by the Department of Defense are underway across active military health systems (e.g., Foa et al, 2017) to determine the methods of training (workshop vs. workshop and consultation) that are most likely to result in the implementation of evidence-based protocols. Another important avenue is that of innovative telemethods that utilize real-time, interactive videoconferencing have been preliminarily supported with regard to efficacy, tolerability, and sustainability (Comer & Barlow, 2014; Dimeff, Paves, Skutch, & Woodcock, 2010).…”

Section: Challenges In Implementation Of Evidence-based Protocols And...mentioning

confidence: 99%

Evidence‐based protocols: Merits, drawbacks, and potential solutions.

Asnaani¹,

Gallagher²,

Foa³

2018

Clinical Psychology: Science and Practice

Self Cite

View full text Add to dashboard Cite

Considerable evidence supports the utility of evidence-based protocols in clinical practice in treating a range of psychological symptoms. However, there are significant barriers to their use. We briefly review theoretical models underlying evidencebased practice and how these relate to use of evidence-based treatment protocols. We then discuss the merits of evidence-based protocols. Common concerns about limitations to using evidence-based protocols in clinical practice follow. Challenges in dissemination and implementation of evidence-based protocols are then reviewed. In addition, current/potential solutions are presented alongside these challenges, to provide suggested avenues for improving the integration of evidence-based protocols into routine clinical practice in a broader range of practice settings moving forward. K E Y W O R D Sdissemination, drawbacks, empirically supported treatments (ESTs), evidence-based protocols, implementation, merits 2 of 13 | ASNAANI et Al.

show abstract

The implementation of prolonged exposure: Design of a multisite study evaluating the usefulness of workshop with and without consultation

Cited by 2 publications

References 35 publications

Bartonella henselaemasquerading as possible gamma–delta T-cell lymphoma in a paediatric patient with 22q11.2 deletion syndrome

Bartonella henselaemasquerading as possible gamma–delta T-cell lymphoma in a paediatric patient with 22q11.2 deletion syndrome

Evidence‐based protocols: Merits, drawbacks, and potential solutions.

Contact Info

Product

Resources

About